• Amit K Mahajan, Jennifer Bautista, Erin Hodson, Sandeep J Khandhar, Erik Folch, Susan Carroll, and Steve Narang.
• Inova Interventional Pulmonology and Complex Airways Disease Program, Division of Thoracic Surgery, Inova Fairfax Medical Campus, Falls Church, VA. Electronic address: amit.mahajan@inova.org.
• Chest. 2020 Sep 1; 158 (3): 1115-1121.

AbstractInterventional pulmonology programs provide clinical benefit to patients and are financially sustainable. To appreciate and illustrate the economic value of interventional pulmonology programs to hospital systems, physicians must have an understanding of basic health-care finance. Total revenue, adjusted gross revenue, contribution margin, variable direct costs, and indirect costs are terms that are essential for understanding the finances of bronchoscopy. Command of such vocabulary and its application is crucial for interventional pulmonologists to successfully establish financially sustainable bronchoscopy programs. Two significant features of an economically sustainable bronchoscopy program are high procedural volume and low direct cost per case. Interventional pulmonology programs are valuable to the patients being served and hospitals as a whole. Consideration of the various factors needed to maintain financial sustainability is essential to improve the quality of care for patients because the cost of care remains a critical driver in defining value.Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

10 keywords...

hide…